Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Jeroen Geldof

Awards & Distinctions

20 Results

2024

Age-related patterns in biological therapy use and surgery among patients with IBD : insights from the Belgian PANTHER cohort

Jade CelisMarie TruyensS VerstocktELIEN GLORIEUSM De WolfM LenfantM BarbaraciJ SabinoM FerranteJeroen Geldof et al.

Disease outcomes and patient’s perspectives after switching biologics from intravenous to subcutaneous administration : a real-world experience in a tertiary IBD-unit

G DewitteS AkhayadMarie TruyensJeroen GeldofTriana Lobatón Ortega

Prophylactic versus endoscopy-driven treatment of Crohn’s postoperative recurrence : a retrospective, multicentric, European study [PORCSE Study]

Jeroen GeldofMarie TruyensMichiel HanssensEmily Van GuchtTom HolvoetAinara ElorzaVincent BouillonSónia BarrosViviana MartinsKonstantinos Argyriou et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

Safety and effectiveness of vedolizumab and ustekinumab in elderly patients with inflammatory bowel disease : a real-life multicentric cohort study

Tom HolvoetMarie TruyensCara De GalanHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui-AmezagaRocio Ferreiro-Iglesias et al.

A1 Journal Article in JOURNAL OF CLINICAL MEDICINE

Successful treatment of ulcerative colitis with anakinra : a case report

Marie TruyensLevi HosteJeroen GeldofAnne HoorensFilomeen HaerynckDIANA HUIS IN 'T VELDTriana Lobatón Ortega

A1 Journal Article in ACTA GASTRO-ENTEROLOGICA BELGICA

The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre

Liesbeth DerooMarie TruyensJeroen GeldofSoumaya AkhayadG DewitteELIEN GLORIEUSTriana Lobatón Ortega

2023

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study

Jeroen GeldofMarie TruyensJoão SabinoMarc FerranteJo LambertHilde LapeereTom HillaryAn Van LaethemKurt de VlamPatrick Verschueren et al.

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

2022

Apoptotic enteropathy, gluten intolerance, and IBD-like inflammation associated with lipotoxicity in DGAT1 deficiency–related diarrhea : a case report of a 17-year-old patient and literature review

Ellen DeoletBert CallewaertJeroen GeldofStephanie Van BiervlietSaskia Vande VeldeJo Van DorpeMyriam Van WinckelAnne Hoorens

A1 Journal Article in VIRCHOWS ARCHIV

Infliximab re-challenge : could it be an option in refractory IBD patients?

Marie TruyensEva Pijoan ComasELIEN GLORIEUSJeroen GeldofTriana Lobatón Ortega

The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study

Cara De GalanMarie TruyensHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui AmezagaRocio Ferreiro- IglesiasTom Holvoet et al.

A1 Journal Article in JOURNAL OF CROHNS & COLITIS

2021

First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)

Jeroen GeldofMarie TruyensJ SabinoM FerranteJo LambertHilde LapeereT HillaryA Van LaethemK De VlamP Verschueren et al.

Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic : results from a Belgian tertiary IBD unit

Goedele DewitteJeroen GeldofMarie TruyensTriana Lobatón Ortega

Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study

Cara De GalanMarie TruyensHarald PeetersFrancisco Mesonero GismeroAinara ElorzaPaola TorresLiv VandermeulenAranzazu Jauregui AmezagaRocio Ferreiro-IglesiasTom Holvoet et al.

The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study

Marie TruyensCara De GalanH PeetersF Mesonero GismeroA ElorzaP TorresL VandermeulenA Jauregui AmezagaR Ferreiro-IglesiasT Holvoet et al.

2020

Clinical implications of decision making in colorectal polypectomy : an international survey of Western endoscopists suggests priorities for change

David TateLobke DesomerSteven J. HeitmanNauzer ForbesNicholas G. BurgessHalim AwadieIan M. GralnekJeroen GeldofDanny De LoozeDouglas Rex et al.

A2 Journal Article in ENDOSCOPY INTERNATIONAL OPEN

Effectiveness of ustekinumab in refractory Crohn's disease : a real-life experience in a tertiary referral centre

Marie TruyensJeroen GeldofG. DewitteELIEN GLORIEUSPieter HindryckxTriana Lobatón Ortega

The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients : a real-life experience of a single-centre cohort

Marie TruyensJeroen GeldofG. DewitteELIEN GLORIEUSGaëlle VarkasDirk ElewautTriana Lobatón Ortega

2019

Efficacy of Ustekinumab intensification and re-induction in Crohn’s disease patients with insufficient or loss of response

Marie TruyensMarleen GoossensELIEN GLORIEUSJeroen GeldofPieter HindryckxTriana Lobatón Ortega

Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease

Marie TruyensMarleen GoossensELIEN GLORIEUSJeroen GeldofPieter HindryckxTriana Lobatón Ortega

2017

Koorts, keelpijn en leverfalen

Marie De GrooteJeroen GeldofAnne HoorensXavier VerhelstRoberto TroisiHarald PeetersHans Van VlierbergheAnja Geerts

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE